Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inter-session reliability of prefrontal cortex functional near-infrared spectroscopy measures during dual-task walking protocols of different duration in stroke survivors and healthy controls.

Neuroscience·2025
Same author

On opportunities and challenges of large multimodal foundation models in education.

NPJ science of learning·2025
Same author

Hebbian plasticity induced by temporally coincident BCI enhances post-stroke motor recovery.

Scientific reports·2024
Same author

Tricuspid transcatheter edge-to-edge repair in a 72-year-old patient with a left ventricular assist device and prior mitral edge-to-edge repair: a case report.

European heart journal. Case reports·2024
Same author

Predictors for Adherence to Recommended Anticoagulation after Stroke Unit Discharge in Patients with Atrial Fibrillation.

Cerebrovascular diseases extra·2024
Same author

The online inverted classroom model (oICM). A blueprint to adapt the inverted classroom to an online learning setting in medical and health education.

MedEdPublish (2016)·2023

Related Experiment Video

Updated: Jun 13, 2026

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

[Diagnosis and therapy in multiple sclerosis].

Michael Sailer1

  • 1MS Ambulanz & Restaurative Neurologie, Neurologische Universitätsklinik, Otto-von-Guericke Universität Magdeburg. michael.sailer@med.ovgu.de

Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS
|May 11, 2010
PubMed
Summary
This summary is machine-generated.

Multiple sclerosis (MS) is a central nervous system inflammatory disease with varied symptoms. Early diagnosis and consistent management, including disease-modifying drugs and relapse treatment, are key for modern MS care.

More Related Videos

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
09:46

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Published on: September 21, 2021

Related Experiment Videos

Last Updated: Jun 13, 2026

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
09:46

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Published on: September 21, 2021

Area of Science:

  • Neurology
  • Immunology
  • Neuroinflammation

Background:

  • Multiple sclerosis (MS) is an inflammatory disease affecting the central nervous system.
  • The initial presentation and disease progression in MS are highly variable.
  • Current diagnostic criteria involve neurological deficits, clinical course assessment, and neuroimaging (MRI).

Purpose of the Study:

  • To outline the diagnostic and therapeutic principles of multiple sclerosis management.
  • To emphasize the importance of early intervention and comprehensive symptom control in MS.

Main Methods:

  • Diagnosis relies on clinical evaluation of neurological deficits and disease course.
  • Magnetic resonance imaging (MRI) of the brain and spine is crucial for diagnosis.
  • Therapeutic strategies include disease-modifying drugs (DMDs), acute relapse management, and escalation therapy per German MS-Therapy-Consensus-Group (MSTKG) guidelines.

Main Results:

  • The heterogeneity of MS necessitates individualized diagnostic and therapeutic approaches.
  • Early initiation of disease-modifying therapies is associated with improved outcomes.
  • Systematic management of acute relapses and chronic symptoms is fundamental to modern MS care.

Conclusions:

  • Effective multiple sclerosis management hinges on early diagnosis and a proactive, multi-faceted therapeutic strategy.
  • Adherence to established treatment guidelines ensures optimal patient care and disease control.
  • Ongoing research continues to refine understanding and treatment of this complex neurological condition.